Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Biologicals : Journal of the International Association of Biological Standardization|February 25, 2006
Effect of relevant culture parameters on Pertussis Toxin expression by Bordetella pertussisMarcel Thalen, Marian Venema, Jan van den IJssel, et al.
Vaccines|September 16, 2020
Manufacture of a Stable Lyophilized Formulation of the Live Attenuated Pertussis Vaccine BPZE1Marcel Thalen, Anne-Sophie Debrie, Loic Coutte, et al.
The Journal of Infectious Diseases|May 24, 2017
Live Attenuated Pertussis Vaccine BPZE1 Protects Baboons Against Bordetella pertussis Disease and InfectionCamille Locht, James F Papin, Sophie Lecher, et al.
Biologicals : Journal of the International Association of Biological Standardization|February 28, 2006
Fed-batch cultivation of Bordetella pertussis: metabolism and Pertussis Toxin productionMarcel Thalen, Marian Venema, Anita Dekker, et al.
Vaccine|December 25, 2007
Improving the cellular pertussis vaccine: increased potency and consistencyMarcel Thalen, Arno van der Ark, Jan van den Ijssel, et al.
The Lancet. Infectious Diseases|July 21, 2020
Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomised, placebo-controlled dose-escalation studyMaja Jahnmatz, Laura Richert, Nabil Al-Tawil, et al.
The Journal of Clinical Investigation|January 17, 2020
Live attenuated pertussis vaccine BPZE1 induces a broad antibody response in humansAng Lin, Danijela Apostolovic, Maja Jahnmatz, et al.
Lancet (London, England)|March 11, 2023
Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine, versus tetanus-diphtheria-acellular pertussis vaccine: a randomised, double-blind, phase 2b trialCheryl Keech, Vicki E Miller, Barbara Rizzardi, et al.
Pageof 1